Polski Bank Komorek Macierzystych SA

What Polski Bank Komorek Macierzystych SA does

Polski Bank Komórek Macierzystych SA (PBKM) is a Warsaw-based cord blood and umbilical cord stem cell bank founded in 2002, operating as the Polish subsidiary of the FamiCord Group, Europe's largest family cord blood banking group. PBKM collects, qualifies, processes, and cryogenically stores hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from Wharton's jelly at its central laboratory in Warsaw (ul. Działkowa 85). As of the source data, the bank holds over 1,000,000 stored samples, has documented 239 cord blood utilizations, and serves patients across more than 80 treatable disease indications, supported by 1,500 cooperating hospitals across Poland and the broader FamiCord network spanning 30+ countries.

The business model is a direct-to-consumer subscription: expectant parents pay an upfront collection/processing fee and recurring annual storage fees, with add-on services such as SwissSafety dual-location storage (Poland and Switzerland), Plum Care genetic testing via Novogenia and Genomed, and NNW school accident insurance through SIGNAL IDUNA. Distribution combines digital marketing (website, paid search, social, email via Sales Manago), a 30+ medical consultant inside-sales team covering all 16 Polish voivodeships, and channel partnerships with hospitals, gynecologists, birthing schools, and midwives. The public cord blood donation program is funded entirely by PBKM in partnership with the Polish Ministry of Health.

The company's competitive position rests on a regulatory moat that is difficult to replicate: PBKM is the only cord blood bank in Poland with AABB accreditation (one of only five in Europe), holds Chief Pharmaceutical Inspector consent for Wharton's jelly therapeutic manufacturing, has maintained ISO 9001 since 2004, and is BBMRI-ERIC certified to ISO 20387:2018. Through FamiCord Group, PBKM is positioned as the commercialization and biobank partner for ExCellThera's Zemcelpro®, which received European Commission conditional marketing authorization in September 2025 as the first expanded cord blood stem cell therapy approved in Europe, extending the company's value proposition from storage services into the therapeutic drug value chain.

Name

Polski Bank Komorek Macierzystych SA

Legal name

Polski Bank Komórek Macierzystych sp. z o.o.

Website

https://pbkm.pl

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Polski Bank Komórek Macierzystych (PBKM) is Poland's largest cord blood and umbilical cord stem cell bank, serving expectant parents through cryogenic storage services across 1,500 hospitals and operating as the Polish entity of FamiCord Group spanning 30+ countries.

Ownership category

akta.pro rank

Product category

Stem Cell Banking Services

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Cord blood banking
• Stem cell storage
• Umbilical cord tissue banking
• Biobanking services
• Regenerative medicine storage

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Family Cord Blood and Stem Cell Banking: Families pay for the collection, processing, and annual storage of cord blood and umbilical cord stem cells. This is a recurring annual fee model with an initial onboarding cost. PBKM offers promotional pricing (e.g., 'Wakacyjne First Minute' summer discounts based on due date/age), referral programs, and returning customer discounts.
2. Complementary and Supplementary Services: Additional paid services including genetic testing (PLUM Care), school accident insurance (NNW SIGNAL IDUNA), and the SwissSafety dual-storage option.
3. Public Cord Blood Donation Program: PBKM funds public cord blood donations in partnership with the Ministry of Health. Parents donate cord blood at selected Warsaw hospitals at no cost, contributing to the national public cord blood bank stock.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

PBKM collects, processes, and cryogenically stores hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from Wharton's jelly (umbilical cord tissue) for families at the time of childbirth, delivering biological material that can be used for future therapeutic treatment of over 80 hematological, oncological, and neurological diseases. Sales and onboarding are direct-to-consumer (website, e-shop, medical consultants) supported by a 1,500-hospital channel partner network enabling collection at delivery across Poland and 30+ countries via FamiCord Group.

Product overview

Polski Bank Komórek Macierzystych SA (PBKM) is a cord blood and stem cell banking service provider operating as Europe's largest family cord blood bank under the FamiCord Group. The company's core offerings center on two biological banking services: cord blood banking (containing hematopoietic stem cells for treating blood disorders and cancers) and umbilical cord stem cell banking (containing mesenchymal cells for regenerative medicine applications including bone, cartilage, and nerve tissue). These are complemented by genetic testing services (Plum Care), SwissSafety dual-location storage, school insurance partnerships, and social programs including public cord blood donation and the Donation to the Rescue program for families with seriously ill children. PBKM operates through a network of 1,500 cooperating hospitals across Europe and maintains AABB accreditation as the only bank in Poland to hold this certification.

Differentiator

Problem solved

Functional benefit

Brands

• SwissSafety: Service enabling storage of collected material in Poland and Switzerland
• Plum Care

Products and services

• Cord Blood Banking (Bankowanie krwi pępowinowej) Collection, testing, processing, and long-term cryogenic storage of umbilical cord blood containing hematopoietic stem cells for potential future therapeutic use by the child and family members in treating blood disorders, cancers, and immune system diseases.
• Umbilical Cord Stem Cell Banking (Bankowanie komórek macierzystych ze sznura pępowinowego) Collection and storage of mesenchymal stem cells from Wharton's jelly (umbilical cord tissue), which have regenerative properties for bone, cartilage, and nerve tissue reconstruction and can be used by family members including parents, siblings, and grandparents.
• Plum Care Genetic Testing (Badania genetyczne Plum Care) Genetic testing services offered by PBKM, including screening tests processed by Novogenia GmbH (Austria) and molecular genetic testing by Genomed S.A. (Warsaw), available as a complement to stem cell banking services.
• SwissSafety Dual-Location Storage Dual-location storage service enabling customers to store their cord blood biological material in both Poland and Switzerland for enhanced security, geographic redundancy, and international accessibility, in partnership with Famicord Suisse SA (Lugano).
• School Accident Insurance NNW SIGNAL IDUNA School accident insurance (NNW - Następstwa Nieszczęśliwych Wypadków) bundled with PBKM's stem cell banking services, provided in partnership with SIGNAL IDUNA Polska TU S.A. (Warsaw) to give coverage for enrolled children.
• Public Cord Blood Bank Donation Program Donation service allowing parents to donate cord blood to a national public bank at no cost, with PBKM funding operational costs in partnership with the Polish Ministry of Health, enabling treatment access for patients unrelated to the donor family.

Quantifiable outcome

• Over 7,368 patients have benefited from stem cell therapies stored at PBKM, with 239 cord blood units utilized in treatment.
• +1 more outcomes

Named customers6 records

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• ExCellTheraflagshipStrategic or Co-development Partner · 10 September 2025ExCellThera developed Zemcelpro® (formerly UM171), the first conditionally authorized (CMA) drug in Europe using expanded cord blood stem cells. FamiCord Group (including PBKM) is partnered with ExCellThera and actively supports the commercialization of this breakthrough therapy for adult patients with hematological malignancies.
• FamiCord GroupcoreStrategic or Co-development PartnerPBKM is the Polish operating entity of FamiCord Group, Europe’s largest family cord blood bank with presence in 30+ countries. FamiCord Group coordinates international operations, R&D in advanced cellular therapies (including ExCellThera’s Zemcelpro®), and provides brand, standards, and strategic direction across all subsidiaries.
• Famicord Suisse SAcoreStrategic or Co-development PartnerFamicord Suisse SA, based in Lugano, Switzerland, is the partner for the SwissSafety service that enables storage of cord blood material in both Poland and Switzerland. PBKM and Famicord Suisse share data processing responsibilities for customers selecting dual-location storage.
• Ministry of Health of PolandflagshipStrategic or Co-development PartnerPBKM partners with the Polish Ministry of Health to operate the public cord blood bank. PBKM funds the entire cost of the public bank from its own resources. Parents can donate cord blood at selected Warsaw hospitals to increase the national public cord blood stock for non-family use.
• SIGNAL IDUNA Polska TU S.A.minorStrategic or Co-development PartnerSIGNAL IDUNA Polska TU S.A. (ul. Siedmiogrodzka 9, Warsaw) is an insurance partner offering group life insurance to PBKM clients. PBKM also shares relevant personal data with SIGNAL IDUNA for insurance enrollment purposes.
• Birthing Schools and Midwives NetworkcoreChannel Partner/ Reseller/ DistributorPBKM partners with over 25 birthing schools and independent midwives across Poland, including institutions in Białystok, Bielsko-Biała, Chorzów, Katowice, Koszalin, Lublin, Łódź, Wrocław, and Zielona Góra. These partners educate expecting parents and refer them to PBKM for cord blood banking services.
• Gynecological Offices and Medical CenterscoreChannel Partner/ Reseller/ DistributorPBKM partners with gynecological offices and medical centers throughout Poland to enable cord blood collection during childbirth and provide information about stem cell banking services to expecting parents.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ViaCord (PerkinElmer): Long-established US family cord blood bank now part of a larger life-sciences platform; comparable core service and customer segment, but embedded in broader diagnostics/genetics portfolio rather than focused on storage.
• Cord Blood Registry (CBR / CooperSurgical): One of the largest US family cord blood banks, owned by CooperSurgical; comparable DTC motion and core product, but embedded within a broader women's-health/fertility portfolio.
• Cryo-Cell International: US-headquartered publicly traded cord blood bank with global operations; comparable DTC family-banking model, but broader portfolio including menstrual stem cell services and longer operating history. Useful as a public-market scale benchmark.

Direct peers

• Cellaviva: Scandinavian (Sweden/Denmark) private cord blood bank within the FamiCord Group offering identical core product — relevant Nordic-market peer for PBKM.
• Crioestaminal: Portuguese cord blood bank operating within the FamiCord Group. Same business model, regulatory framework, and parent organization as PBKM; directly comparable for European family banking analysis.
• Sevibe Cells: Spanish family cord blood and tissue bank within the FamiCord network operating the Iberia market; identical product offering and customer segment to PBKM.
• SmartCells International: UK-based private cord blood bank with operations also in Hong Kong and UAE; sibling FamiCord subsidiary serving the British market. Offers core cord blood + tissue storage with comparable medical-consultant-led GTM motion.
• Biogenis: Romanian cord blood bank serving as a FamiCord subsidiary; directly comparable family-banking product, regulatory context (EU), and customer segment.
• Vita 34 AG: Germany's leading family cord blood bank, operating as a direct PBKM subsidiary partner within the FamiCord Group. Directly comparable product offering (cord blood and tissue banking), customer segment (expectant parents), and regulatory position (GMP/FDA-equivalent).
• Krio Intézet: Hungarian family cord blood bank within the FamiCord Group; sibling entity with identical model serving the Hungarian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC9EhQM-9Us2qgjEkMc4PeVQ
• Facebookpl-pl.facebook.com/krew.pepowinowa
• LinkedInlinkedin.com/company/polish-stem-cells-bank-pbkm-
• Instagraminstagram.com/pbkm.pl

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polski Bank Komorek Macierzystych SA